Clinical Trial

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Study acronym: MOMENTOUS
Recruiting
View on ClinicalTrials.gov →
Summary
MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
Protocol Amendment History 3 changes
notable Trial sites expanded: 25 -> 30 locations 2026-07-03
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-05-05
notable Enrollment reduced: 1000 -> 900 participants 2026-05-05
Trial Details
NCT Number NCT06911632
Lead Sponsor Tempus AI
Collaborators: United Therapeutics
Conditions Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Enrollment 900 participants
Start Date 2025-07-23
Primary Completion 2028-05 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-04